Calamos Announces Upside Cap Ranges for Upcoming Structured Protection ETFs Providing Exposure to S&P 500 and Nasdaq-100 with 100% Downside Protection Over One YearPRNewsWire • 02/14/25
Gelesis®, the Maker of Plenity® for Weight Management, Will Debut as a Publicly Traded Company Following the Closing of Its Business Combination with CapstarBusiness Wire • 01/13/22
Gelesis Adds Inogen Co-Founder and Former CFO Ali Bauerlein to Board of Directors and Audit CommitteeBusiness Wire • 01/05/22
Have Your Cake and Eat It Too: Plenity® Creates Edible Dessert Billboard to Challenge Overly Restrictive Dieting AssumptionsBusiness Wire • 12/16/21
Gelesis' FDA-Cleared Weight Management Approach, Plenity®, Now Broadly Available and Leading Nutrition Authority Joy Bauer, MS, RDN, CDN, Joins as Chief Nutrition OfficerBusiness Wire • 12/01/21
Capstar Special Purpose Acquisition Corp. and Gelesis Revise Transaction TermsBusiness Wire • 11/10/21
Nature's Scientific Reports Features Gelesis' Novel and Foundational Biomimetic Platform for Treating Obesity and Conditions Related to Diet-Induced Gut DamageBusiness Wire • 11/01/21
FDA-Approved Weight Loss Drug Plenity's Parent Announces SPAC Deal: What Investors Should KnowBenzinga • 07/19/21
Gelesis, a Consumer-Focused Biotherapeutics Company and the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp.Business Wire • 07/19/21